David I Vernon
Overview
Explore the profile of David I Vernon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Conway C, Walker I, Bell A, Roberts D, Brown S, Vernon D
Photochem Photobiol Sci
. 2008 Apr;
7(3):290-8.
PMID: 18389145
Increasing treatment specificity is one of the major aims of cancer research. Photodynamic therapy is a clinically proven treatment for some cancers and certain other diseases. Photosensitisers generally have little...
2.
Walker I, Gorman S, Cox R, Vernon D, Griffiths J, Brown S
Photochem Photobiol Sci
. 2004 Jul;
3(7):653-9.
PMID: 15239000
Photodynamic therapy (PDT) is a treatment combining a photosensitiser, molecular oxygen and visible light of characteristic wavelength to produce cytotoxic reactive oxygen species (ROS). Within our centre, a series of...
3.
van den Akker J, Holroyd J, Vernon D, Sterenborg H, Brown S
Lasers Surg Med
. 2004 Mar;
34(2):141-5.
PMID: 15004826
Background And Objectives: (Pre)cancerous skin lesions accumulate more protoporphyrin IX (PpIX) upon topical application of 5-aminolevulinic acid (ALA) than the surrounding normal skin. This might be the result of a...
4.
van den Akker J, Boot K, Vernon D, Brown S, Groenendijk L, van Rhoon G, et al.
Photochem Photobiol Sci
. 2004 Mar;
3(3):263-7.
PMID: 14993942
An approach to induce increased protoporphyrin IX (PpIX) production in aminolevulinic acid (ALA)-based photodynamic therapy (PDT) of skin lesions is to elevate the skin temperature during topical ALA application. Increased...
5.
Walker I, Vernon D, Brown S
Bioorg Med Chem Lett
. 2003 Dec;
14(2):441-3.
PMID: 14698177
It has been demonstrated that efficient site-specific coupling of the highly active photodynamic therapy sensitiser purpurin-18 to the synthetic targeting peptide G-G-V-K-R-K-K-K-P-G-Y-G can be achieved with greater than 85% purity.
6.
van den Akker J, Holroyd J, Vernon D, Sterenborg H, Brown S
Lasers Surg Med
. 2003 Sep;
33(3):173-81.
PMID: 12949947
Background And Objectives: ALA esters have been developed to improve PpIX production in ALA-PDT, but they do not perform as well in skin as they do in cells and the...
7.
Mellish K, Cox R, Vernon D, Griffiths J, Brown S
Photochem Photobiol
. 2002 May;
75(4):392-7.
PMID: 12003129
We have synthesized a series of symmetrical phenothiazines in which the methyl groups of methylene blue have been substituted by longer alkyl chains. Intrinsic photosensitizing ability was not altered by...